Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000296595 | SCV000373642 | uncertain significance | Mitochondrial complex I deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000349342 | SCV000373643 | uncertain significance | Leigh syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000416264 | SCV000493687 | uncertain significance | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002520743 | SCV003706080 | uncertain significance | Inborn genetic diseases | 2022-08-02 | criteria provided, single submitter | clinical testing | The c.1188G>A (p.M396I) alteration is located in exon 9 (coding exon 9) of the NDUFV1 gene. This alteration results from a G to A substitution at nucleotide position 1188, causing the methionine (M) at amino acid position 396 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000416264 | SCV003932286 | uncertain significance | not provided | 2023-02-02 | criteria provided, single submitter | clinical testing | PM2 |
Mayo Clinic Laboratories, |
RCV000416264 | SCV000802793 | uncertain significance | not provided | 2016-02-26 | no assertion criteria provided | clinical testing |